Wahl Bryan (CIK 0001841401)

Latest company ownership

TARS - Tarsus Pharmaceuticals, Inc.

Role: General Counsel

Shares held

51,712

Last filed at

Mar 20, 2025

Confidence Score

49.9

2025Q4

Confidence Score History

2022Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 18, 2025	Mar 20, 2025	Tarsus Pharmaceuticals, Inc.	General Counsel	Sell	40.0	-9,686	-15.78%	✗	$463.8K
Mar 15, 2024	Mar 19, 2024	Tarsus Pharmaceuticals, Inc.	General Counsel	Sell	42.5	-4,436	-9.77%	✗	$135.7K
Nov 29, 2023	Dec 1, 2023	Tarsus Pharmaceuticals, Inc.	General Counsel	Sell	42.5	-8,356	-20.72%	✗	$136.3K
Mar 21, 2023	Mar 23, 2023	Tarsus Pharmaceuticals, Inc.	General Counsel	Sell	46.3	-1,078	-6.17%	✗	$13.5K
Mar 17, 2023	Mar 21, 2023	Tarsus Pharmaceuticals, Inc.	General Counsel	Sell	47.5	-696	-3.83%	✗	$9K
Mar 15, 2023	Mar 17, 2023	Tarsus Pharmaceuticals, Inc.	General Counsel	Sell	47.5	-337	-1.82%	✗	$4.5K
Dec 2, 2022	Dec 6, 2022	Tarsus Pharmaceuticals, Inc.	General Counsel	Sell	46.3	-1,154	-7.76%	✗	$19.5K
Nov 29, 2022	Dec 1, 2022	Tarsus Pharmaceuticals, Inc.	General Counsel	Sell	46.3	-2,347	-13.63%	✗	$39K